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Abstract: Although Staphylococcus aureus is part of the normal body flora, heavy usage of antibiotics
has resulted in the emergence of methicillin-resistant strains (MRSA). MRSA can form biofilms
and cause indwelling foreign body infections, bacteremia, soft tissue infections, endocarditis,
and osteomyelitis. Using an in vitro assay, we screened 173 clinical blood isolates of MRSA and
selected 20 high-biofilm formers (H-BF) and low-biofilm formers (L-BF). These were intravenously
administered to mice and the general condition of mice, the distribution of bacteria, and biofilm
in the liver, lung, spleen, and kidney were investigated. MRSA count was the highest in the liver,
especially within Kupffer cells, which were positive for acid polysaccharides that are associated with
intracellular biofilm. After 24 h, the general condition of the mice worsened significantly in the H-BF
group. In the liver, bacterial deposition and aggregation and the biofilm-forming spot number were
all significantly greater for H-BF group than for L-BF. CFU analysis revealed that bacteria in the H-BF
group survived for long periods in the liver. These results indicate that the biofilm-forming ability of
MRSA is a crucial factor for intracellular persistence, which could lead to chronic infections.
Keywords: MRSA; virulence; biofilm; intracellular persistence; Kupffer cells; mice
1. Introduction
Staphylococcus aureus is a human pathogen that causes a range of illnesses, from minor skin
infections to life-threatening disease. Methicillin-resistant S. aureus (MRSA) is one of most detectable
microbes in hospital-acquired infections, and causes device-associated infections, bacteremia, soft
tissue infections, endocarditis, and osteomyelitis [1–3]. MRSA has emerged as a significant threat in
both hospital and community environments [4]. With limited treatment options, MRSA infections are
associated with high mortality [5].
MRSA forms biofilms not only on indwelling medical devices and implants but also in tissues.
Bacterial biofilm is thought to be an important factor in chronic infections. Biofilms are mainly
composed of extracellular polysaccharides (EPS) produced by bacteria, and they also contain proteins
and extracellular DNA [6–8]. Many S. aureus genes are involved in biofilm formation, including fnb, ica,
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agr, and sarA. The extracellular polysaccharide adhesin PIA/PNAG, which is encoded by the icaADBC
locus, is responsible for the biofilm-forming phenotype [9]. Although elimination of biofilm is an
important issue in medical practice, no effective methods are available.
Bacterial invaders adopt sophisticated strategies against host antimicrobial immunity in vivo.
S. aureus biofilm can attenuate host pro-inflammatory responses and escape macrophage phagocytosis
by evasion of Toll-like receptors [10]. Another important mechanism is enhanced drug resistance,
especially in the biofilm state, which is explained by the presence of persisters and/or decreased
drug permeability [6,11,12]. However, how biofilms exhibit ten to a thousand times increase in drug
resistance compared to that of planktonic bacteria remains unknown.
In a healthy host, invading bacteria are generally ingested by phagocytic cells including
macrophages, monocytes and neutrophils [13] and then digested and killed by lysosomal enzymes.
However, a hallmark of staphylococcal infection is frequent recurrence as the bacteria manipulate host
immune responses [14]. Bacteria also implement another strategy for intracellular survival [15–17]:
they hide like Trojan Horses inside the cell and may only become virulent in immune-compromised
patients. These bacteria include not only common parasitic bacteria such as Shigella, Salmonella, and
Mycobacterium tuberculosis, but also S. aureus [18].
An epidemiological study using S. aureus from long-lasting bovine mastitis showed that in vitro
bacterial internalization in bovine mammary epithelial cells is related to accessory gene regulator
(agr) group I, but not to agr group II or biofilm formation [19]. It has been reported that internalized
S. aureus is able to replicate inside pulmonary epithelial cells and induce apoptosis [20]. However, this is
arguably a disadvantage for the bacteria in losing an intracellular safety location, since in this location,
they are able to escape many host defense mechanisms and shield themselves from extracellular
antimicrobial antibiotics. Survival of S. aureus within the macrophage phagosome requires specific
mechanisms against normal microbicidal reactions. Das et al. (2008) [21] showed that catalase and
superoxide dismutase produced by S. aureus combat intracellular oxygen species, allowing S. aureus
to persist within macrophages. Another mechanism of intracellular survival of S. aureus is the small
colony variant (SCV) [22,23]. However, the precise intracellular mechanisms of S. aureus survival
in vivo are still unclear.
In the present study, to clarify the relationship between biofilm-forming ability and intracellular
bacterial survival, clinical isolates of MRSA were intravenously injected into mice. MRSA isolates
were then divided into two groups, high and low, by their biofilm-forming ability in vitro. Bacterial
tissue distribution, including intracellular localization, was examined. This in vivo study showed that
biofilm is important for intracellular MRSA survival and virulence.
2. Results
2.1. MRSA Isolates and Genotypes
OJ-1, a previously reported biofilm-forming isolate that had been collected from a wound
surface [24], was used as the control. In a study based on differences in biofilm-forming ability,
20 clinical MRSA isolates from blood specimens were selected and classified as the low-biofilm formers
(L-BF; 10 isolates) and high-biofilm formers (H-BF; 10 isolates) (Table 1). Mean Crystal violet (CV)
levels for biofilm-forming ability in the H-BF group were significantly higher than that in the L-BF
group (0.126 ˘ 0.02 and 1.232 ˘ 0.208, respectively, p < 0.001). No considerable difference was found
between the two groups in terms of genotype (i.e., agr, SCCmec, ica, and fnbA) involvement in MRSA
virulence and biofilm formation (Table 1 and Table S1).
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Table 1. Profiles of methicillin-resistant strains (MRSA) isolates. Summarized data of clinically isolated
bacteria in the L-BF and H-BF groups, including biofilm-related genes and biofilm-forming ability (CV
value in vitro). In addition, shown are each of the spot numbers from the photograph of liver tissue,
including the Gram-stained spot number (G), more than 10 µm2 of Gram-stained spot number (G ě 10),
and ALB-stained spot number 24 h after intravenous bacterial injection. Their physical condition
classification is also indicated.
Group Site
(W/B) Name
agr SCCmec icaA icaD fnbA CV
Spot number per
liver photo Physical
condition
G G>10 ALB
H-BF W OJ-1 II NT + + + 1.000 30 5 7 3
L-BF
B T87 I II + + + 0.087 21 1 1 1
B T104 II II + + + 0.105 34 4 3 1
B T96 II II + + + 0.117 24 4 2 1
B T101 II II + + + 0.124 32 6 2 3
B T109 II II + + + 0.124 28 4 5 1
B T90 II II + + + 0.125 16 1 2 1
B T153 II II + + + 0.128 20 1 3 1
B T126 II II + + + 0.140 51 7 3 1
B T2 I NT + + - 0.151 33 6 2 4
B T8 III IV + + + 0.156 40 2 3 1
H-BF
B T146 II II + + + 0.980 31 6 3 4
B T125 II II + + + 1.078 34 6 4 4
B T34 II II + + + 1.107 25 3 8 1
B T166 II II + + + 1.112 26 3 3 4
B T32 II II + - + 1.116 36 9 4 1
B T144 II II + + + 1.138 35 6 6 1
B T41 I NT + + + 1.183 29 5 4 4
B T38 II II + + + 1.447 43 9 5 3
B T141 II II + + + 1.560 37 9 6 2
B T37 II II + + + 1.601 36 6 4 2
W: wound; B: blood
2.2. Detection of Extracellular Polysaccharides in Biofilm in the Liver
Among the mice that received injections of MRSA isolates, some showed localized necrotic
foci inside the liver. For the mice that showed bacterial clusters in the liver, serial sections were
examined by different staining (Figure 1 and Figure S1). Colonies were present inside the necrotic
foci, and their size ranged from 10 to 50 µm in diameter. Gram-positive bacterial nuclei were stained
by hematoxylin and were also found to be positive for anti-S. aureus antibody. To detect biofilm
matrixes, mucopolysaccharide staining was used. PAS staining for natural mucopolysaccharides failed
to show any specific tissue localization. Meanwhile, when iron colloid staining, toluidine blue staining
(pH 2.5), and Alcian blue staining (pH 2.5) (ALB) for acidic mucopolysaccharides were utilized, all of
the staining was positive in the bacterial colonies. In addition, double staining using ALB staining and
immunostaining of S. aureus was used to examine the relationship between the bacterial body and the
extracellular polysaccharides. The results showed that circular and granular bacteria were assembled
together and were surrounded by a biofilm matrix containing acidic mucopolysaccharides. Because of
the detection capability of ALB staining, as well as its simplicity and broad histological utility, ALB
staining was used for the following studies.
MRSA colonies had developed inside necrotic regions of the liver 24 h after bacterial injection, and
were stained with HE staining, Gram staining, and immunostaining using an anti-S. aureus antibody.
Acidic mucopolysaccharide staining, specifically iron colloid staining (Fe colloid), toluidine blue
staining (pH 2.5) (TB), and Alcian blue staining (pH 2.5) (ALB), was also used. The bacterial cells and
the extracellular polysaccharides were examined by a means of double staining using ALB and S. aureus
antibody (ALB + SA). The surrounding matrix (blue) was positive for acidic mucopolysaccharides.
Bars = 50 µm.
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Figure 1. Detection of methicillin‐resistant S. aureu (MRSA) colonies and their biofilm matrix in the 
liver. 
MRSA colonies had developed inside necrotic regions of the liver 24 h after bacterial injection, 
and were  stained with HE  staining, Gram  staining,  and  immunostaining using  an  anti‐S.  aureus 
antibody. Acidic mucopolysaccharide staining, specifically iron colloid staining (Fe colloid), toluidine 
blue staining (pH 2.5) (TB), and Alcian blue staining (pH 2.5) (ALB), was also used. The bacterial cells 
and the extracellular polysaccharides were examined by a means of double staining using ALB and S. 
aureus antibody (ALB + SA). The surrounding matrix (blue) was positive for acidic mucopolysaccharides. 
Bars = 50 μm. 
2.3. Time‐Course of Bacterial Distribution and MRSA in Each Organ 
A bacterial solution of OJ‐1 was intravenously injected into mice, and tissue distributions in the 
liver, lungs, spleen, and kidneys were examined at 1, 3, 6, 12, and 24 h. After tissue specimens were 
stained by Gram staining and ALB staining, the stained spots were morphometrically analyzed. The 
number of Gram‐positive spots in the tissues (bacterial density) as well as the number of ALB‐positive 
spots (extent of biofilm formation) was evaluated. Tissue bacterial density was lower in the kidneys 
than in the liver, lungs, and spleen (Figure 2). Although a time‐course decrease in bacterial counts 
was  found  in all organs, persistence of residual bacteria was highest  in  the  liver. Meanwhile,  the 
number of ALB‐positive  spots was highest  in  the  liver,  showing  that bacterial accumulation was 
greater in the liver than in other organs and was maintained even 24 h after bacterial injection. Similar 
results for tissue distribution, especially in the H‐BF group, were also found in isolated bacteria from 
the blood. 
Figure 1. Detection of methicillin-resistant S. aureu (MRSA) colonies and their biofilm matrix in the liver.
2.3. Time-Course of Bacterial Distribution and MRSA in Each Organ
A bacterial solution of OJ-1 was intravenously injected into mice, and tissue distributions in the
liver, lungs, spleen, and kidneys were examined at 1, 3, 6, 12, and 24 h. After tissue specimens were
stained by Gram staining and ALB staining, the stained spots were morphometrically analyzed. The
number of Gram-positive spots in the tissues (bacterial density) as well as the number of ALB-positive
spots (extent of biofilm formation) was evaluated. Tiss e bacterial density was lower in the kidneys
than in the liver, lungs, and spleen (Figure 2). Although a time-course decrease in bacterial counts was
found in all organs, persistence of residual bacteria was highest in the liver. Meanwhile, the number of
ALB-positive spots was highe in the liver, showing that bacterial accumulation was greater in the
liver than in other organs and was maintained even 24 h after bacterial injection. Similar results for
tissue distribution, especially in the H-BF group, were also found in isolated bacteria from the blood.
The tissue distribution of OJ-1 in the liver, lung, spleen, and kidney was examined at 1, 3,
6, 12, and 24 h after intravenous bacterial injection. Tissue bacterial density was evaluated using
Gram-stained specimens as a reference, as shown in Figures S2–S5. The number of ALB-positive spots
was counted. Value: mean ˘ SEM.
Both the Gram-positive and ALB-positive spots were distributed diffusely in the liver (Figure 3A).
In order to investigate the details of the distribution profiles, S. aureus that had been subjected to double
staining were observed by microscopy with strong magnification (Figure 3B, left). The images show
the presence of several units to dozens of bacteria inside the ALB-positive spots, distributed primarily
in Kupffer cells in the hepatic sinusoid. The electron microscopic picture also shows that intracellular
bacteria are localized in the membrane-associated vacuole in a Kupffer cell (Figure 3B, right).
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Figure 2. Time‐course of bacterial density (left) and ALB spot number in different organs (right). 
The tissue distribution of OJ‐1 in the liver, lung, spleen, and kidney was examined at 1, 3, 6, 12, 
and  24  h  after  intravenous  bacterial  injection.  Tissue  bacterial  density  was  evaluated  using   
Gram‐stained specimens as a reference, as shown in Figures S2–S5. The number of ALB‐positive spots 
was counted. Value: mean ± SEM. 
Both the Gram‐positive and ALB‐positive spots were distributed diffusely in the liver (Figure 3A). 
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double staining were observed by microscopy with strong magnification (Figure 3B, left). The images 
show the presence of several units to dozens of bacteria inside the ALB‐positive spots, distributed 
primarily in Kupffer cells in the hepatic sinusoid. The electron microscopic picture also shows that 
intracellular bacteria are localized in the membrane‐associated vacuole in a Kupffer cell (Figure 3B, right). 
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Figure 3. Intrahepatic distribution of bacteria and ALB‐positive material. (A) Representative histological 
aspects of liver tissues with Gram staining and ALB staining (red circles) performed at 1, 12, and 24 h 
after intravenous injection of OJ‐1. Bars = 50 μm; (B) Double staining of liver tissues using ALB and S. 
aureus antibody (SA) (left). ALB‐positive spots were found inside the cells (red circles), and several 
units  to  dozens  of  S.  aureus  antibody‐positive  bacteria were  visible  at  the  same  site.  In  electron 
microscopy  (right),  intracellular bacteria are  localized  in  the vacuole, probably  in  the phagosome. 
Based on the cellsʹ morphology and localization, they are Kupffer cells. Bars = 5 μm. 
2.4. Time‐Course of Intrahepatic Bacterial Accumulation 
To examine the distribution pattern of OJ‐1 in liver tissues, the number and surface area of spots 
at Gram‐positive sites were analyzed. The aforementioned sites could be classified into two categories. 
One of the histograms showed a monomodal distribution of surface areas of 10 μm2 or less. Meanwhile, 
at sites containing spots with larger areas, another distribution was bimodal at the 10 μm2 spot, which 
showed intracellular accumulation/aggregation of bacteria. 
We  examined  the  time‐course  of  the  number  of  Gram‐positive  spots  in  liver  tissues  after 
intravenous injection of OJ‐1 (Figure 4, top), the number of Gram‐positive spots with an area of 10 μm2 
or greater (Figure 4, center), and the number of ALB‐positive spots (Figure 4, bottom). Although the 
number of Gram‐positive spots was small during the first hour after injection, it increased thereafter 
to a number that was maintained for 24 h. Meanwhile, the number of spots with aggregated bacteria 
with a surface area of 10 μm2 or greater increased with time during the 24 h of the study. Although 
the number of ALB‐positive spots showed temporal variation, it stabilized after the first 3 h and did 
not decrease considerably. Similar results of time‐dependent alteration in the three parameters were 
found in isolated bacteria from the blood. These results support that bacteria injected into the blood 
accumulate/aggregate in liver tissues, and are retained in liver tissues up to 24 h. 
Figure 3. Cont.
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aureus antibody (SA) (left). ALB‐positive spots were found inside the cells (red circles), and several 
units  to  dozens  of  S.  aureus  antibody‐positive  bacteria were  visible  at  the  same  site.  In  electron 
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Figure 3. Intrahepatic distribution of bacteria and ALB-positive material. (A) Representative
histological aspects of liver tissues with Gram staining and ALB staining (red circles) performed
at 1, 12, and 24 h after intravenous injection of OJ-1. Bars = 50 µm; (B) Double staining of liver tissues
using ALB and S. aureus antibody (SA) (left). ALB-positive spots were found inside the cells (red
circles), and several units to dozens of S. aureus antibody-positive bacteria were visible at the same
site. In lectron microsco y (ri ht), intr cellular bacte ia are localized in the vacuole, probably in the
phagosome. Based on the cells' morphology and localization, they are Kupffer cells. Bars = 5 µm.
2.4. Time-Course of Intrahepatic Bacterial Accumulation
To examine the distribution pattern of OJ-1 in liver tissues, the number and surface area of spots
at Gram-positive sites were analyzed. The aforementioned sites could be classified into two categories.
One of the histograms showed a monomodal distribution of surface areas of 10 µm2 or less. Meanwhile,
at sites containing spots with larger areas, another distribution was bimodal at the 10 µm2 spot, which
showed intracellular accumulation/aggregatio of acteria.Toxins 2016, 8, 198  7 of 17 
 
 
Figure 4. Time‐dependent changes in tissue distribution patterns of Gram‐positive and ALB‐positive 
spots. This  figure  shows  the  time‐course  of  the number of Gram‐positive  spots  in  the  liver  after 
injection of OJ‐1 (top); number of Gram‐positive spots with a surface area of 10 μm2 or greater (center); 
and number of ALB‐positive spots (bottom). Value: mean ± SEM. 
2.5. Relationship between Intrahepatic Bacterial Accumulation with the L‐BF and H‐BF Groups 
We examined the correlation between the number of bacterial aggregation spots measuring 10 μm2 
or greater and the number of ALB‐positive spots (Figure 5). No correlation was found between the 
two parameters.  In addition,  in  the L‐BF group, no significant correlation was  found between  the 
numbers of the two types of spots, whereas in the H‐BF group, an increase in the number of bacterial 
aggregation spots was accompanied by a significant increase in the number of ALB‐positive spots   
(p < 0.04). 
Figure 4. Time-dependent changes in tissue distribution patterns of Gram-positive and ALB-positive
spots. This figure shows the time-course of the number of Gram-positive spots in the liver after injection
of OJ-1 (top); number of Gram-positive spots with a surface area of 10 µm2 or greater (center); and
number of ALB-positive spots (bottom). Value: mean ˘ SEM.
Toxins 2016, 8, 198 7 of 17
We examined the time-course of the number of Gram-positive spots in liver tissues after
intravenous injection of OJ-1 (Figure 4, top), the number of Gram-positive spots with an area of 10 µm2
or greater (Figure 4, center), and the number of ALB-positive spots (Figure 4, bottom). Although the
number of Gram-positive spots was small during the first hour after injection, it increased thereafter to
a number that was maintained for 24 h. Meanwhile, the number of spots with aggregated bacteria
with a surface area of 10 µm2 or greater increased with time during the 24 h of the study. Although
the number of ALB-positive spots showed temporal variation, it stabilized after the first 3 h and did
not decrease considerably. Similar results of time-dependent alteration in the three parameters were
found in isolated bacteria from the blood. These results support that bacteria injected into the blood
accumulate/aggregate in liver tissues, and are retained in liver tissues up to 24 h.
2.5. Relationship between Intrahepatic Bacterial Accumulation with the L-BF and H-BF Groups
We examined the correlation between the number of bacterial aggregation spots measuring
10 µm2 or greater and the number of ALB-positive spots (Figure 5). No correlation was found between
the two parameters. In addition, in the L-BF group, no significant correlation was found between the
numbers of the two types of spots, whereas in the H-BF group, an increase in the number of bacterial
aggregation spots was accompanied by a significant increase in the number of ALB-positive spots
(p < 0.04).Toxins 2 16, 8, 198  8 of 17 
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2.7. General Condition of ice after Injection of S
t 24 after bacterial injection, the general condition of the mice was compared using a four-level
e aluation (Figure 6B). Worsening of the general conditi was found to be significantly more severe
in the H-BF group than in the L-BF group (p < 0.01). In addition, comparison based on fatalities among
the mice revealed that 8 out of 30 mice (27%) died in the L-BF group and 16 out of 30 mice (53%) died
in the H-BF group, showing that the fatality rate w s 2 times higher in the H-BF group than in the L-BF
group (p < 0.05).
2.8. Persistence of MRSA in the Liver
To avoid acute effects after bacterial injection, 1/2 diluted bacterial solution was utilized. At 24 h
after injection, physical condition was not worsen, and bacteremia was virtually absent in both of
the groups. The number of viable bacteria (log-CFU) in the liver was 2.8 ˘ 0.3/mg in L-BF and
3.8 ˘ 1.4/mg in L-BD and H-BF, respectively (p < 0.001).
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Persistence of viable bacteria in the liver was also examined for longer periods of time (1, 3, and
4 days). The representative data are shown in Figure 7. On day 1, the number of viable bacteria in
T37 (H-BF) was slightly higher than that in T104 (L-BF), but was not significant. Both of the levels
decreased on day 3. Subsequently, the level in T37 was elevated about two-fold on day 4. Its level was
also significantly higher than that of T104 (p < 0.05). Bacteremia and deterioration of total condition
were only found in T37 on days 3 and 4 of the study.
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examined on days 1, 3, and 4. Deterioration of physical condition and bacteremia were only found in
H-BF (T37) on days 3 and 4. The viable bacter al count in the liver on day 4 was significantly higher in
mice treated with T37 than in hose treated with T104 (L-BF). Value: mean ˘ SEM.
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To date, there have been no reports of methods for the proper detection of RSA biofilms within
tissue sa ples. Once S. aureus enter the host’s body, their proteinaceous and non-proteinaceous
adhesins ediate attach ent to the extracellular atrix and cells [25]. They then produce extracellular
aterials and for biofil s. In order to detect biofil s for ed within tissues, a staining ethod for
polysaccharides was used, given that polysaccharides are present in large amounts in biofilms. EPS is
known to have multi-functions, including the aintenance of biofil structures, resistance to drugs,
and evasion from the attacks of i mune cells [7,8]. Staining of bacterial growth regions associated
with necrotic foci formed inside the mice’s liver showed that while neutral mucopolysaccharides were
negative in the atrix at the site of bacterial aggregation, the latter contained large a ounts of acidic
ucopolysaccharides. Meanwhile, with CV, a dye co monly used in biofilm research conducted
in vitro, all components inside the tissue specimens were stained (unpublished data); therefore, CV
staining could not be used for tissue studies. Acid mucopolysaccharides can also be found in mast
cells, mesothelial cells, and goblet cells; therefore, caution is needed when searching for them in tissues.
owever, fro a pathological vie point, the acid ucopolysaccharide staining ethod, especially
LB staining, hich can be used for double staining, is si ple, convenient, and effective for the
identification of biofil in RSA-infected tissues. In addition to this, orphological observation and
Gra staining should also be perfor ed.
Enterotoxin, leukocidin, and toxic shock syndrome toxin (TSST) are kno n cytotoxic toxins
produced by S. aureus [26,27]. e did not check the production of such toxins in the isolates. In the
present study, bacterial culture solution at optical density of = 1.0 as considered to be a critical
concentration to the mice. Some of the mice started to exhibit bacteremia 12 h after injection, and
a deterioration of the general condition was found for so e isolates. o ever, hen 1/2-diluted
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bacterial solutions were used, the general condition was not affected for 24 h, even in the case of
bacteria with the highest virulence. Therefore, bacterial solutions with an optical density of OD = 1.0
were used for the comparison of MRSA isolates in terms of tissue distribution and bacterial virulence.
One hour after injection of bacterial solution, most of the bacteria were distributed in hepatic,
pulmonary, and splenic tissues; however, the bacterial count in the kidneys was lower and may have
been dependent on phagocytosis systems. The time-course of bacterial tissue distribution showed that
the bacterial counts in the liver remained unchanged, whereas those in the lungs and spleen decreased,
suggesting that tissue distribution may be dependent upon bactericidal activity inside those tissues.
This organ-specific distribution was also found in all of the isolates. Therefore, this may be a common
phenomenon after MRSA enters the bloodstream. Meanwhile, the number of ALB-positive spots,
which served as an indicator of putative biofilm formation, remained high only in the liver. In addition,
the presence of biofilm was associated with the presence of bacteria inside Kupffer cells in the liver,
and was accompanied by an increase in the size of clusters of intracellular bacteria, suggesting that the
bacteria may have remained and/or proliferated intracellularly. In addition, the viable bacterial count
in liver tissues at 24 h of the study also showed that a large number of bacteria were still present at
that time. Phenol-soluble modulins (PMSs) are peptides involved in the maintenance and survival of
endocytosed S. aureus. They are responsible for the destruction of the phagosome membrane, and are
known to evade digestion [28].
Intracellular parasitism is a known phenomenon in certain bacteria, including Listeria,
Salmonella, and Mycobacterium tuberculosis, which settle in host cells using various strategies against
endosome-lysosomal and autophagy-based degradation systems [18,29–31]. A number of previous
studies have shown that S. aureus may also survive intracellularly [16,32,33]. Various cells, such as
epithelial cells [29,33,34], endothelial cells [35], and leukocytes including macrophages [17,21,36,37]
and osteoblasts [38], have been reported to be invaded by persistent S. aureus. After invasion of a cell,
S. aureus is believed to achieve survival by producing small colony variants (SCVs) [22,32,39]. On the
other hand, when they are under stress due to pharmacological agents, bacteria have been reported to
increase the appearance of persisters inside biofilms [11], and they favor conversion into SCV in host
cells [12]. The bacterial distribution pattern inside liver tissues found in our study showed that the
presence of ALB-positive substances in bacteria might help them to form biofilms and to convert into
variants intracellularly.
In the present study, we examined biofilm activity in 173 clinical isolates. They showed a
biologically normal distribution, from which the L-BF and H-BF isolates were selected. The presence of
many of putative genes was checked as an essential factor for biofilm formation, but no difference was
noted in the groups. It has been shown that regulatory genes, such as icaADBC [9] and msaABCB [40],
influence biofilm development and virulence. Gene expression may change due to in vitro and in vivo
circumstances. We plan to examine such gene expression in a future study.
The relationship between the biofilm-forming ability of MRSA and its bacterial virulence remains
entirely unknown. Our previous study of foreign body infections using mice has shown that biofilm
was crucial for bacterial survival in vivo [24]. However, it has been reported that biofilm is not a
required condition for foreign body infection [41]. In the present study, when clinical isolates of MRSA
were cultured under a comparable condition, each isolate showed a reproducible biofilm-forming
ability. Comparison between the BF-L group and the BF-H group showed that the latter group induced
a robust virulence in mice. In other words, the biofilm-forming ability observed in vitro may reflect an
important influencing factor for bacterial survival inside a tissue cell; however, its intracellular kinetics
still remain unknown. In fact, the virulence of some bacterial isolates in mice was not consistent
with grouping. Hence, biofilm-forming ability is not the only determinant of virulence. However,
identification of the biofilm-forming ability of MRSA in infected patients may serve as a reference for
the determination of patient prognosis. Therefore, prospective studies will be needed in the future.
When bacterial virulence is induced, the condition of the infected organism is likely to shift to
bacteremia, and tissue infection by bacteria is likely to be exacerbated. Therefore, given that the general
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condition was maintained within a normal range for all bacterial isolates inoculated as 1/2-diluted
bacterial solutions, mice were injected with this amount of bacteria, and bacterial viability in the liver
was compared at 24 h after injection. The findings showed that viable bacteria were 20-fold more
numerous in the H-BF group than in the L-BF group. We furthermore checked their survival at longer
periods up to 4 days. The number of viable cells decreased from 1 day to 3 days in both groups.
However, the number of viable bacteria increased on day 4 in H-BF, but not in L-BF. This indicates that
H-BF bacteria survived and started to proliferate inside the liver after a longer period of time. These
results also support our hypothesis that biofilm-forming bacteria can persist intracellularly.
Biofilm-forming bacteria are known to have an enhanced resistance to the host’s immunity as
well as antibiotics [6]. Biofilms are believed to develop drug resistance as a result of not only physical
causes, such as a decreased permeability to drugs, but also bacterial conversion into persisters and/or
dormant cells [6,7,42,43]. Our study suggested that after being phagocytosed, bacteria formed a
biofilm intracellularly and evaded intracellular bactericidal mechanisms. Intracellular bacteria may
slowly invade and extend into the hepatic tissue accompanied by extracellular biofilm, and form
a large necrotic lesion after 10 days. Difficult strategies are required in order to overcome this, as
antibiotics must achieve intracellular penetration. However, Lehar et al (2015) [44] recently proposed a
novel method allowing for the elimination of S. aureus responsible for intracellular infection through
antibody-antibiotic complexes. Development of effective treatment methods for the removal of
intracellular S. aureus will be needed in the future.
Our study used a mouse model of bacteremia to show that the biofilm-forming ability of MRSA
was important for maintaining the survival of bacteria in the host's body, and that MRSA was capable
of intracellular persistence that could lead to chronic infection.
4. Experimental Sections
4.1. MRSA Isolates
We used one isolate of MRSA (OJ-1), which had been collected from the surface of an ulcerated
wound and was kept at the Department of Plastic, Reconstructive, and Aesthetic Surgery, Fukuoka
University Hospital. In addition, we also used a collection of 173 isolates of MRSA that had been kept
at Fukuoka University Hospital, Department of Internal Medicine, Division of Oncology, Hematology
and Infectious Diseases [45]. The bacterial isolates were thawed from the stocks and were incubated
on Tryptic Soy Agar (TSA) (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) containing
0.5% NaCl. When colonies formed, one colony was collected and scattered in 5 mL of Tryptic Soy
Broth (TSB) (Becton, Dickinson and Company) in 12 mL plastic test tubes with screw caps (SARSTEDT,
Tokyo, Japan), and bacterial culture was carried out at 37 ˝C [24]. Those that achieved a stable growth
were cultured on agar again, and colonies formed were stored at 4 ˝C and were used in experiments
within one month.
4.2. Extent of Biofilm Formation
Each MRSA isolate’s extent of biofilm formation was measured using the modified CV staining
method [46]. Bacteria were harvested from TSA, suspended in test tubes containing 5 mL of TSB, and
cultured at 37 ˝C for 24 h. Floating bacteria were discarded, and the biofilm that was adhering to the
wall was washed with a phosphate buffer solution (PBS, pH 7.4). Then, 100% ethanol was added,
and the samples were dried and subjected to CV staining for 10 minutes. After staining, the samples
were washed in running water until the dye was completely eluted, and the dye that was attached to
the surface of the test tubes was dissolved with 3 mL of 30% acetic acid. The absorbance of the dye
solution (absorbance wavelength 570 nm) was measured using a spectrophotometer (GENESYS 10S
VIS, Thermo Scientific, LMS, Tokyo, Japan). For all measurements conducted on clinical isolates from
blood specimens, OJ-1 was used as a reference MRSA [24] and the CV values for all the tested isolates
were calculated by considering that the CV value of OJ-1 was 1. The measurements of CV values
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were performed in triplicates and the mean values were considered the CV value for each isolate. On
the basis of the extent of biofilm formation, 10 isolates with the highest biofilm-forming ability and
10 isolates with the lowest biofilm-forming ability were selected, and were classified as high-biofilm
former (H-BF) and low-biofilm former (L-BF), respectively (Table 1).
4.3. Genotypic Characterization
In accordance with the previously reported method [47,48], genotypes agr, SCCmec, sea, sec, sed, see,
seg, she, sei, sej, sem, sen, tsst-1, icaA, icaD, hla, hlb, fnb, and fnbB were amplified by PCR, and confirmation
of the presence of fragments for these genes was carried out on the basis of band appearance and
pattern using agarose gel electrophoresis.
4.4. Administration of MRSA Bacterial Solutions to Mice
The animal experiments that were carried out in this study had received prior approval from
Fukuoka University Animal Center’s animal experiment approval committee (approval number:
1512884, 11 December 2015). One colony was harvested from the agar medium, suspended in TSB,
and cultured at 37 ˝C. Bacterial culture in exponential phase was continued until the absorbance at
a wavelength of 578 nm reached 1.0. A viable bacterial count at OD = 1, as assessed by CFU assay,
showed no difference between isolates (about 2 ˆ 104 CFU/µL), and they were within 10% variation.
Bacterial growth was then stopped by placing the TSB on ice, and the resulting bacterial solution was
administered to animals in the subsequent experiments. In the experiments, the bacterial solution
was used in its original concentration (ˆ1) or diluted two-fold in TSB (1/2 dilution). Preliminary
experiments have shown that when the bacterial solutions were used at a concentration of ˆ1,
intravenous administration of bacteria of different species resulted in various systemic symptoms.
Therefore, they were used for comparing the overall condition of the mice on the basis of differences
in the MRSA isolates, as well as for determining the tissue distribution of bacteria. When used at a
concentration of 1/2 dilution, neither of the bacterial solutions caused any considerable change in the
mice's overall condition, and only a minimum number developed bacteremia; therefore, 1/2 dilution
was used to study bacterial viability within tissues. Two hundred microliters of bacterial solution
were administered to the caudal vein of female C57BL/6N mice between the ages of 6 to 10 weeks
(Japan SLC Inc., Shizuoka, Japan) under anesthesia. At 1, 3, 6, 12 and 24 h and 3 and 4 days after
administration of the bacterial solutions, the mice were killed by cervical dislocation and their organs
(liver, lungs, spleen, and kidneys) were harvested and fixed in 10% neutral formalin.
4.5. Assessment of the Animals' Condition
A four-stage evaluation (1: normal, 2: hypoactive, 3: inactive, 4: dead) was used for the assessment
of the animals' general condition after administration of bacteria. The evaluation of each bacterium
was based on the mean value found in each mouse.
4.6. Histological Staining Method
The formalin-fixed tissues were washed with water, and paraffin blocks were prepared in a
way that all 4 types of organs were contained in the same blocks. The paraffin blocks were cut
into 4 µm-thick slices using a microtome, serial sections were attached onto a glass slide, and the
necessary staining was performed. As general histological staining, hematoxylin-eosin staining (HE)
and Gram staining were performed. As for acid mucopolysaccharide staining [49], Alcian blue
staining (pH 2.5) (ALB), Toluidine blue staining (pH 2.5) (TB) and iron colloid staining (Fe colloid)
were performed. As for neutral mucopolysaccharide staining, periodic acid-Schiff stain (PAS) was
performed and immunostaining was carried out using an HRP-labeled anti-S. aureus antibody (ViroStat,
Inc., Portland, ME, USA), and staining was developed using diamino benzidine after the reaction. For
double staining with ALB, immunostaining was carried out after ALB staining.
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4.7. Photographs of Tissue Samples for Analysis
The specimens that had been subjected to Gram staining and ALB staining were photographed
using an optical microscope (Bio-Zero, KEYENCE Co., Osaka, Japan) on which observations were
conducted with a 20ˆ objective lens, and pictures were taken at 3 different locations where bacteria
were present in the largest number inside the organs (image area: 134 ˆ 103 µm2, image resolution:
680 ˆ 512 picts).
4.8. Morphometry
(1) Semi-quantitative evaluation of Gram-positive spots
Evaluation of tissue bacterial density: A four-level semi-quantitative evaluation method was
carried out using Gram-stained specimens (0: absence of bacteria, 1: small amounts of bacteria,
2: moderate amounts of bacteria, 3: large amounts of bacteria). During the evaluations, image
assessment of the photographs was carried out in blind, in reference to basic photographs that were
considered as evaluation criteria. Reference photographs are Figure S2 for the liver, Figure S3 for the
spleen, Figure S4 for the lung, and Figure S5 for the kidney. Mean values were used for the evaluations
conducted on each bacterial isolate.
(2) Measurement of the number of Gram-positive spots
The photographs were imported into image analysis software (VH Analyzer ver2.60, KEYENCE
Co., Kyoto, Japan), where a length calibration was performed, all Gram-positive spots with a size
equal to or greater than 2 picts in the images were extracted, the number of positive spots was counted,
and the area of each spot was measured. In addition, the number of spots with an area equal to or
greater than 10 µm2 was also measured.
(3) Relevance of the area size of Gram-positive spots
To examine the bacterial distribution pattern of MRSA in hepatic tissues, spots in positive sites in
Gram-staining photographs were numbered and their surface areas were measured. Their cumulative
frequency distribution was analyzed using histograms.
(4) Measurement of the number of ALB-positive spots
The photographs of ALB-stained tissues were printed on A4-size photographic paper. ALB
positive spots were detected macroscopically and counted. Three different people performed
evaluations in blind, and the mean value was adopted as the value for the bacterial isolate.
4.9. Measurement of the Viable Bacterial Count within Liver Tissue
A bacterial solution with an optical density of OD = 1 (about 2 ˆ 104 CFU/µL) was diluted two
fold in TSB, and 200 µL of the resulting solution was administered to mice intravenously through
the caudal vein. Twenty-four hours later, blood samples were collected from the orbital cavity; liver
tissues were also harvested and stored on ice. Blood samples and liver tissue samples, which had
been processed with a homogenizer (Polytron PT 1200E: KINEMATICA AG, Luzern, Switzerland),
were 10-times serially diluted and inoculated onto TSA. Bacterial culture was carried out at 37 ˝C
for 24 h, and the number of colonies was counted as a colony-forming unit (CFU). For blood samples,
the results were expressed as the number of colonies per µL, and for the liver tissue samples, the
results were expressed as the number of colonies per mg of wet weight.
4.10. Statistical Analysis
Comparison of the two groups was carried out using the Student t-test and the chi-square test.
Correlations between 2 factors were examined by linear regression analysis. The cumulative frequency
distribution of the sizes of bacterial aggregates in the tissues was analyzed using histograms. p values
<0.05 were considered significant.
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Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/8/7/198/s1,
Table S1: Data of genes related to biofilm formation; Figure S1: A large infected necrotic lesion in the liver
of a mouse 10 days after OJ-1 injection. After injection of OJ-1 ˆ1 solution, some mice survived and their
general condition was fine 10 days after bacterial injection; however, large extracellular necrotic lesions were
sometimes developed in the liver. The lesion was examined for biofilm formation. The result was similar
to the lesion 24 h after injection (Figure 1); many MRSA colonies developed around the necrotic focus, and
they were accompanied with acidic polysaccharides detected by Colloidal Fe, ALB, and TB staining, but were
negative for neutral polysaccharides (PAS). The double staining of ALB + SA showed a biofilm matrix containing
acidic mucopolysaccharides; Figure S2: Reference picture for grading of gram-positive MRSA in the liver. Each
liver picture was evaluated using a set of reference pictures for the grading of gram-positive MRSA; Figure S3:
Reference picture for grading of gram-positive MRSA in the spleen. Each spleen picture was evaluated using
a set of reference pictures for the grading of gram-positive MRSA; Figure S4: Reference picture for grading of
gram-positive MRSA in the lung. Each lung picture was evaluated using a set of reference pictures for the grading
of gram-positive MRSA; Figure S5: Reference picture for grading of gram-positive MRSA in the kidney. Each
kidney picture was evaluated using a set of reference pictures for the grading of gram-positive MRSA.
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TSST toxic shock syndrome toxin.
PMSs Phenol-soluble modulins.
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